![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: SFT2D1 |
Gene summary for SFT2D1 |
![]() |
Gene information | Species | Human | Gene symbol | SFT2D1 | Gene ID | 113402 |
Gene name | SFT2 domain containing 1 | |
Gene Alias | C6orf83 | |
Cytomap | 6q27 | |
Gene Type | protein-coding | GO ID | GO:0006810 | UniProtAcc | Q8WV19 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
113402 | SFT2D1 | HTA11_347_2000001011 | Human | Colorectum | AD | 1.21e-03 | 3.15e-01 | -0.1954 |
113402 | SFT2D1 | HTA11_99999970781_79442 | Human | Colorectum | MSS | 1.44e-03 | 3.64e-01 | 0.294 |
113402 | SFT2D1 | HTA11_99999965104_69814 | Human | Colorectum | MSS | 5.44e-06 | 4.90e-01 | 0.281 |
113402 | SFT2D1 | A015-C-203 | Human | Colorectum | FAP | 1.57e-04 | -1.89e-01 | -0.1294 |
113402 | SFT2D1 | A002-C-201 | Human | Colorectum | FAP | 4.59e-02 | -1.06e-01 | 0.0324 |
113402 | SFT2D1 | A002-C-205 | Human | Colorectum | FAP | 1.69e-04 | -1.57e-01 | -0.1236 |
113402 | SFT2D1 | A015-C-006 | Human | Colorectum | FAP | 4.77e-03 | -2.13e-01 | -0.0994 |
113402 | SFT2D1 | A015-C-106 | Human | Colorectum | FAP | 1.39e-02 | -1.28e-01 | -0.0511 |
113402 | SFT2D1 | A002-C-114 | Human | Colorectum | FAP | 1.62e-03 | -1.78e-01 | -0.1561 |
113402 | SFT2D1 | A015-C-104 | Human | Colorectum | FAP | 1.55e-04 | -1.65e-01 | -0.1899 |
113402 | SFT2D1 | A001-C-014 | Human | Colorectum | FAP | 1.42e-02 | -1.68e-01 | 0.0135 |
113402 | SFT2D1 | A002-C-116 | Human | Colorectum | FAP | 2.29e-03 | -1.33e-01 | -0.0452 |
113402 | SFT2D1 | A018-E-020 | Human | Colorectum | FAP | 3.87e-03 | -1.32e-01 | -0.2034 |
113402 | SFT2D1 | LZE2T | Human | Esophagus | ESCC | 3.63e-06 | 4.76e-01 | 0.082 |
113402 | SFT2D1 | LZE4T | Human | Esophagus | ESCC | 1.41e-19 | 3.01e-01 | 0.0811 |
113402 | SFT2D1 | LZE5T | Human | Esophagus | ESCC | 6.59e-05 | 6.68e-01 | 0.0514 |
113402 | SFT2D1 | LZE7T | Human | Esophagus | ESCC | 4.29e-09 | 7.39e-01 | 0.0667 |
113402 | SFT2D1 | LZE8T | Human | Esophagus | ESCC | 3.52e-14 | 6.20e-01 | 0.067 |
113402 | SFT2D1 | LZE20T | Human | Esophagus | ESCC | 2.99e-09 | 3.32e-01 | 0.0662 |
113402 | SFT2D1 | LZE22D1 | Human | Esophagus | HGIN | 4.04e-05 | 9.90e-02 | 0.0595 |
Page: 1 2 3 4 5 6 7 8 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Esophagus | ESCC | ![]() |
Skin | AK | ![]() |
Skin | SCCIS | ![]() |
Skin | cSCC | ![]() |
Thyroid | HT | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
SFT2D1 | SNV | Missense_Mutation | c.138N>A | p.Phe46Leu | p.F46L | Q8WV19 | protein_coding | tolerated(1) | benign(0) | TCGA-AA-3510-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | |
SFT2D1 | SNV | Missense_Mutation | rs201063880 | c.133G>A | p.Val45Ile | p.V45I | Q8WV19 | protein_coding | tolerated(1) | benign(0.003) | TCGA-AA-A00N-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | PD |
SFT2D1 | SNV | Missense_Mutation | rs201063880 | c.133N>A | p.Val45Ile | p.V45I | Q8WV19 | protein_coding | tolerated(1) | benign(0.003) | TCGA-CA-6717-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Chemotherapy | oxaliplatin | CR |
SFT2D1 | SNV | Missense_Mutation | novel | c.464N>A | p.Ser155Tyr | p.S155Y | Q8WV19 | protein_coding | deleterious(0) | possibly_damaging(0.876) | TCGA-A5-A0G2-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD |
SFT2D1 | SNV | Missense_Mutation | rs769925855 | c.211N>A | p.Gly71Ser | p.G71S | Q8WV19 | protein_coding | deleterious(0.02) | probably_damaging(1) | TCGA-A5-A0G2-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD |
SFT2D1 | SNV | Missense_Mutation | novel | c.254N>A | p.Pro85His | p.P85H | Q8WV19 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-AX-A3G9-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | carboplatin | SD |
SFT2D1 | SNV | Missense_Mutation | novel | c.250N>A | p.Gly84Arg | p.G84R | Q8WV19 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-EO-A22U-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
SFT2D1 | SNV | Missense_Mutation | c.318N>T | p.Leu106Phe | p.L106F | Q8WV19 | protein_coding | tolerated(0.07) | possibly_damaging(0.55) | TCGA-97-7547-01 | Lung | lung adenocarcinoma | Female | >=65 | I/II | Chemotherapy | vinorelbine | PD | |
SFT2D1 | SNV | Missense_Mutation | novel | c.461G>C | p.Cys154Ser | p.C154S | Q8WV19 | protein_coding | deleterious(0.04) | benign(0.396) | TCGA-MN-A4N5-01 | Lung | lung adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
SFT2D1 | SNV | Missense_Mutation | novel | c.378A>T | p.Leu126Phe | p.L126F | Q8WV19 | protein_coding | deleterious(0.01) | possibly_damaging(0.76) | TCGA-BR-8361-01 | Stomach | stomach adenocarcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD |
Page: 1 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |